Category: News and press

The JPIAMR held its 39th Management Board meeting in Rome, Italy, on 18-19 March where members from over 20 countries met to share information and to discuss the planning and progress of the future European Partnership on One Health AMR (OHAMR).

In the frame of the meeting, a workshop on the future OHAMR Partnership Work Packages was conducted together with representatives from additional countries that have expressed interest to join the OHAMR partnership.

This was the last physical JPIAMR Management Bord meeting before the launch of OHAMR in the spring of 2025 and also the last meeting for the Head of Secretariat Laura Marin, who will be leaving JPIAMR in April, 2024.

The Management Board thanked Laura for more than 10 years of great contribution and instrumental efforts in making the JPIAMR successful and being recognised as a key actor in the coordination and support of international AMR research. 

Patriq Fagerstedt will be the Acting Head of JPIAMR Secretariat, temporarily.

The preparation for the future European Partnership on One Health AMR (OHAMR) is progressing and the draft Roadmap of Actions has now been published. The Roadmap of Actions delineates the actions that will be undertaken during the lifetime of the partnership (2025-2032) to address the objectives of the Strategic Research and Innovation Agenda. The Roadmap of Actions will be implemented through an Annual Work Programme for each year, providing a more detailed description of the planned actions.

The OHAMR partnership will be a co-funded research and innovation (R&I) partnership, expected to start 2025 under the Horizon Europe R&I framework programme. The partnership will coordinate and boost AMR R&I in an interdisciplinary One Health approach, contributing to advanced knowledge, innovative solutions and policy to reduce the burden of AMR.

• Download the OHAMR Roadmap of Actions (pdf 4 MB)

This Roadmap of Actions has been developed by partners in the CSA DESIGN OH AMR, with the contribution of JPIAMR members, additional funders who have expressed interest to join OHAMR, the JPIAMR Scientific Advisory Board, as well as other experts and relevant stakeholders. A series of consultations have also been conducted.

• Read more about the OHAMR partnership

The JPIAMR activity report now published summarises the achievements of JPIAMR and the major events conducted in the year 2023.

It has been a year of future preparations but also of many exciting activities, awarding new projects in the area of diagnostics and surveillance, analysing the impacts of the JPIAMR project portfolio, starting an Early Research Career contest and much more.

• Download the JPIAMR Activity Report 2023

The call Interventions moving forward to promote action to counteract the emergence and spread of bacterial and fungal resistance and to improve treatments is now open.

The primary aim of the call is to take action against the growing global threat of increased spread of antimicrobial (antibacterial and antifungal) resistance by funding international collaborative research projects aiming to improve, compare and evaluate the effectiveness, cost effectiveness, and uptake of existing interventions against bacterial or fungal infections and/or to design new interventions against fungal infections. It involves 21 funding organisations from 19 different countries and has an estimated total call budget of over 17,7 million Euro.

The call will follow a two-step evaluation procedure and the deadline for pre-proposals is 14 March 2024. The full call text and the link to the online submission platform can be found on the call page: 

• Call page “AMR Interventions 2024”

Webinar for applicants

A live webinar for applicants will be organised on the 24th of January 2024 at 13.00-14.30 CET. This webinar will present the call and the partner search tool. Representatives from funders participating in the call will answer questions live.

• Registration page Webinar for applicants

JPIAMR launched a contest for young scientists to present their lab’s project supported by JPIAMR using LinkedIn. Eligible participants were young scientists under the supervision of PIs with projects supported by JPIAMR in the calls 2019-2022. The contest was open between 20 October and 20 November 2023.

There were 11 eligible contestants who participated, and together their posts raised 66 000 impressions!

On the 14th of December the winners were announced and they presented their projects, which can be seen on the JPIAMR youtube channel.

The three winners and projects are: 

• 1st place: CycleDrug, Hans Carolus
• 2nd place: PHAGE-EX 1, Anna-Delia Knipper
• 3rd place: STARS-TAP, Elisabeth Derollez

We are pleased to pre‐announce the transnational call Interventions moving forward to promote action to counteract the emergence and spread of bacterial and fungal resistance and to improve treatments.

The primary aim of the call is to take action against the growing global threat of increased spread of antimicrobial (antibacterial and antifungal) resistance by funding international collaborative research projects aiming to improve, compare and evaluate the effectiveness, cost effectiveness, and uptake of existing interventions against bacterial or fungal infections and/or to design new interventions against fungal infections.

The call involves 21 funding organisations from 19 different countries and has an estimated total call budget of over 19 million Euro.

The call opens on January 10, 2024.

Read more on the call page.

Seventeen projects involving 93 partners from 23 different countries have been recommended for funding within the JPIAMR 16th transnational call: Development of innovative strategies, tools, technologies, and methods for diagnostics and surveillance of antimicrobial resistance. The call was within the framework of the ERA‐NET JPIAMRACTION and the total requested funding amount is 20,8 M€.

The projects aim to address unmet needs in the AMR diagnostics and surveillance sectors beyond the current state of the art, by focusing on the two topics of the call:

• To develop novel, or improve existing, diagnostics, including point of care diagnostics, that can rule out antimicrobial use or help identify the most effective antimicrobial treatment.
• To develop or improve existing strategies, technologies or methods, or data use strategies to support One Health AMR surveillance.

Read more about the projects

The preparation for the future European Partnership on One Health AMR (OHAMR) is progressing and the first draft of the Strategic Research and Innovation Agenda (SRIA) has now been published. The SRIA will guide the activities of the OHAMR partnership, a co-funded research and innovation (R&I) partnership expected to start 2025 under the Horizon Europe R&I framework programme. The partnership will coordinate and boost AMR R&I in an interdisciplinary One Health approach, contributing to advanced knowledge, innovative solutions and policy to reduce the burden of AMR.

• Download the OHAMR Strategic Research and Innovation Agenda (pdf 3 MB)

A detailed description of each Research and Innovation objective of the SRIA is also available in a seperate document.

• Download the Research and Innovation Objectives of the SRIA (pdf 2 MB)

The SRIA and the R&I objectives have been developed by the CSA DESIGN OH AMR together with the JPIAMR Scientific Advisory Board and other experts, through a series of consultations with member states and stakeholders.

The current SRIA should be considered as a preliminary draft and will be subjected to several consultations before it is adopted by the OHAMR partners by the start of the Partnership in 2025.

• Read more about the OHAMR partnership

The European Commission has adopted a proposal for a Council Recommendation on stepping up EU actions to combat antimicrobial resistance in a One Health approach, in which the future European partnership on One Health AMR (OH AMR) is highlighted. This proposal extends and complements the 2017 EU One Health Action Plan against AMR in all three dimensions of the One Health spectrum in order to maximize synergies and attain a strong and effective response against AMR across the EU. 

• Read the press release

The research and Innovation angle is reflected throughout the Council Recommendation. The proposal invites the Member States to strengthen support to R&D:

“The Council welcomes the Commission’s intention to and Member States are invited to: Support research and technological innovation for the detection, prevention and treatment of infections in humans caused by antimicrobial resistant pathogens, including the establishment of and significant investment in a European partnership to allow coordination, alignment and funding of cross-sectorial research and innovation on “One Health AMR”

It also call Member States to contributing to the efforts in tackling infectious diseases and AMR in low and middle-income countries, such as through the Global Health EDCTP3 JU.

The key objectives of this proposal for a Council Recommendation are:

• strengthen One Health national action plans on AMR
• reinforce surveillance and monitoring of AMR and antimicrobial consumption
• strengthen infection prevention and control
• strengthen antimicrobial stewardship and prudent use of antimicrobials
• recommend targets for AMR and antimicrobial consumption in human health
• improve awareness, education and training
• foster research & development, and incentives for innovation and access to antimicrobials and other AMR medical countermeasures
• increase cooperation
• enhance global actions